5, 95% CI: 318.5; P < 0.001) and maximum T-wave shape index < 0.007 (odds ratio: 180.0,

95% CI: 10.2-3167.0; P < 0.0001).\n\nConclusion T-wave shape index selleck chemicals llc is rate dependent and discriminates between PES- and PES+ patients. We propose patients with inducible arrhythmias have rate-dependent heterogeneity of repolarization which could be a tool for risk stratification.”
“Objective To investigate procedural success rates and long-term clinical outcome of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in elderly patients. Background Little is known about procedural success and long-term clinical outcome of PCI for CTO in the elderly. Methods A total of 1,791 consecutive patients with 1,852 CTO underwent PCI at three large centers in USA, Italy, and South Korea. selleck inhibitor Outcomes included procedural success and major adverse cardiac events (MACE, composite of mortality, myocardial infarction, or coronary artery bypass graft surgery [CABG]).Time-to-event analyses were performed using Kaplan-Meier statistics, and the log-rank statistic was used to test for differences between patients aged 75 and patients aged <75 years. Results Two hundred and thirteen patients (12%) were aged 75 years. Procedural success rates were similar in elderly patients compared with patients <75 years (63.8% vs. 69.1%,

P = 0.12). Median follow-up was 890 days (IQR: 380-1,480 days). MACE rates after successful versus failed PCI were 25.8% versus 42.3% in the elderly (P = 0.02) and 11.2 versus 20.8% in younger patients (P < 0.01). In elderly patients, this

reduction in MACE after successful PCI was mainly driven by a reduction in CABG (0.0% vs. 20.4%, P < buy LY2835219 0.01), there were no significant differences in terms of mortality (19.6% vs. 24.6%, P = 0.13) or MI (11.5% vs. 8.0%, P = 0.87). Conclusion CTO PCI in patients 75 years has similar success as in patients <75 years. In elderly patients undergoing CTO PCI, MACE rates were relatively high but successful revascularization is associated with a reduction in MACE at 5-year follow-up in both elderly and younger patients. (c) 2013 Wiley Periodicals, Inc.”
“Background: The European Commission has an Impact Assessment (IA) procedure that aims to inform decision-makers of the all important impacts that decisions may have. This article studies how health is considered in the IA procedure and how it is reflected in the reports: what aspects, whose and simply in what context health is mentioned in the IA reports. Methods: Half of the Commissions IAs from 2006 were studied. The analysis was text based and informed by content analysis. In total, 48 reports by 17 DGs were analysed. Results: Five DGs (29%) and 10 reports (21%) made no reference to human health, public health or health systems. Five DGs were clearly considering health impacts more often than others; DG EMPL, SANCO, AGRI, ELARG and ENV.